J.S. Rader
Washington University School of Medicine
St. Louis
MO 63110
USA
Name/email consistency: low
- A phase II study to determine the efficacy and tolerability of intravenous ZD9331 in heavily pretreated patients with ovarian cancer. Rader, J.S., Clarke-Pearson, D., Moore, M., Carson, L., Holloway, R., Kao, M.S., Wiznitzer, I., Douglass, E.C. Gynecol. Oncol. (2003)